Literature DB >> 28396196

Enhancing reproducibility: Failures from Reproducibility Initiatives underline core challenges.

Kevin Mullane1, Michael Williams2.   

Abstract

Efforts to address reproducibility concerns in biomedical research include: initiatives to improve journal publication standards and peer review; increased attention to publishing methodological details that enable experiments to be reconstructed; guidelines on standards for study design, implementation, analysis and execution; meta-analyses of multiple studies within a field to synthesize a common conclusion and; the formation of consortia to adopt uniform protocols and internally reproduce data. Another approach to addressing reproducibility are Reproducibility Initiatives (RIs), well-intended, high-profile, systematically peer-vetted initiatives that are intended to replace the traditional process of scientific self-correction. Outcomes from the RIs reported to date have questioned the usefulness of this approach, particularly when the RI outcome differs from other independent self-correction studies that have reproduced the original finding. As a failed RI attempt is a single outcome distinct from the original study, it cannot provide any definitive conclusions necessitating additional studies that the RI approach has neither the ability nor intent of conducting making it a questionable replacement for self-correction. A failed RI attempt also has the potential to damage the reputation of the author of the original finding. Reproduction is frequently confused with replication, an issue that is more than semantic with the former denoting "similarity" and the latter an "exact copy" - an impossible outcome in research because of known and unknown technical, environmental and motivational differences between the original and reproduction studies. To date, the RI framework has negatively impacted efforts to improve reproducibility, confounding attempts to determine whether a research finding is real.
Copyright © 2017 Elsevier Inc. All rights reserved.

Keywords:  Peer review; Reproducibility; Scientific self-replication

Mesh:

Year:  2017        PMID: 28396196     DOI: 10.1016/j.bcp.2017.04.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Opinion: Is science really facing a reproducibility crisis, and do we need it to?

Authors:  Daniele Fanelli
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

Review 2.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288

Review 3.  The Academic-Industrial Complexity: Failure to Launch.

Authors:  Leonard A Levin; Francine Behar-Cohen
Journal:  Trends Pharmacol Sci       Date:  2017-10-27       Impact factor: 14.819

4.  The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.

Authors:  Vicki L Sutherland; Charlene A McQueen; Donna Mendrick; Donna Gulezian; Carl Cerniglia; Steven Foley; Sam Forry; Sangeeta Khare; Xue Liang; Jose E Manautou; Donald Tweedie; Howard Young; Alexander V Alekseyenko; Frank Burns; Rod Dietert; Alan Wilson; Connie Chen
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 5.  Ten Basic Rules of Antibody Validation.

Authors:  Michael G Weller
Journal:  Anal Chem Insights       Date:  2018-02-08

6.  Ensuring reproducibility and ethics in animal experiments reporting in Korea using the ARRIVE guideline.

Authors:  Mi-Hyun Nam; Myung-Sun Chun; Je-Kyung Seong; Hoon-Gi Kim
Journal:  Lab Anim Res       Date:  2018-03-22

Review 7.  While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.

Authors:  Yan He; Chengfu Yuan; Lichan Chen; Yanjie Liu; Haiyan Zhou; Ningzhi Xu; Dezhong Joshua Liao
Journal:  Int J Med Sci       Date:  2018-01-19       Impact factor: 3.738

8.  Aedes aegypti (Aag2)-derived clonal mosquito cell lines reveal the effects of pre-existing persistent infection with the insect-specific bunyavirus Phasi Charoen-like virus on arbovirus replication.

Authors:  Anthony C Fredericks; Tiffany A Russell; Louisa E Wallace; Andrew D Davidson; Ana Fernandez-Sesma; Kevin Maringer
Journal:  PLoS Negl Trop Dis       Date:  2019-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.